PMS14 A COST-EFFECTIVENESS ANALYSIS OF BIOLOGICAL AGENTS FOR PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS FOLLOWING INADEQAUTE RESPONSE TO METHOTREXATE
May 1, 2008, 00:00
10.1016/S1098-3015(10)70816-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)70816-0/fulltext
Title :
PMS14 A COST-EFFECTIVENESS ANALYSIS OF BIOLOGICAL AGENTS FOR PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS FOLLOWING INADEQAUTE RESPONSE TO METHOTREXATE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70816-0&doi=10.1016/S1098-3015(10)70816-0
First page :
Section Title :
Open access? :
No
Section Order :
566